Kory James Wentworth
CFO & TreasurerMr. Kory James Wentworth, CPA., has been Chief Financial Officer and Treasurer of Entrada Therapeutics, Inc. since November 2020. Mr. Wentworth served as Vice President of Finance of bluebird bio, Inc. since December 18, 2017 until October 02, 2020. Mr. Wentworth served as Treasurer at bluebird bio, Inc since March 2018 until October 02, 2020 and also served as its Principal Accounting Officer. Mr. Wentworth joined bluebird bio, Inc. from Alexion Pharmaceuticals, Inc., where he held positions of increasing responsibility for finance and accounting teams from December 2008 to December 2017, including Executive Director and Corporate Controller from November 2017 to December 2017, as Executive Director and Assistant Controller from September 2016 to October 2017 and as Senior Director and Assistant Controller from January 2012 to August 2016. Mr. Wentworth held positions at PricewaterhouseCoopers LLP of increasing responsibility for audit engagements from October 2002 to December 2008. Mr. Wentworth received his B.S. in Accounting from Susquehanna University from 1997 to 2001. He is a licensed Certified Public Accountant.
公司職務
- 公司名稱Entrada Therapeutics, Inc.股票代碼TRDA職務CFO & Treasurer共事同僚
- DDDipal DoshiCEO & Director
- KMKush M. ParmarIndependent Chairman of the Board
- NJNathan J. DowdenPresident & COO
- NSNatarajan SethuramanPresident of Research & Development
- JCJared CohenGeneral Counsel
- MTMary T. ThistleIndustry Leader & Independent Director
- PSPeter S. KimDirector
- BGBernhardt G. ZeiherIndependent Director
